RSS

cancer drug

A retrospective cohort study has found no conclusive evidence that most oncology treatments approved for use by the EMA offered survival or quality of life benefits to patients, giving rise to calls for an increase in the evidence bar. more

News

In a statement from Janet Woodcock, director of the Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), it has been revealed that the investigational use of Keytruda (pembrolizumab) has been halted due to safety concerns. more

News

Partner to pharmaceutical and biotech companies 3M Drug Delivery Systems announced a collaboration with therapeutic drug development company, Panacea Pharmaceuticals. more

News

A drug used to treat breast cancer has been rejected for use on the NHS due to its high cost. more

News

Contract Development, Manufacturing and Packaging Organisation, Quay Pharma has entered into an agreement with drug discovery and development company, Redx Pharma, to manufacture its new cancer treatment drug. more

News

Merck, Array BioPharma and Pierre Fabre have initiated a prospective, randomised, global phase three clinical trial for a treatment of BRAF-mutant metastatic colorectal cancer (mCRC) more

News

Bayer and Orion today announced the expansion of the global clinical development programme for an investigational androgen receptor (AR) antagonist in the area of prostate cancer more

News

Scientists have identified a chemical compound that is highly effective at blocking the growth of breast cancer cells. more

News

The high-pressure environment of pancreatic cancer tumours are behind most drugs failing, according to researchers from the Fred Hutchinson Cancer Research Center more

News

An award to progress a lung cancer candidate into the clinic has been given to Queen’s University Belfast and Domainex more

News

Sanofi today announced that it has sent a letter to Medivation, in which it makes a proposal to acquire Medivation for £36.09 ($52.50) per share, which would represent an all-cash transaction valued at approximately £6.4bn ($9.3bn) more

News

breast-cancer-cells-stained-for-dna-(red)-nfkb-(green)-and-a-reactive-oxygen-species-probe-(blue)-julia-sero-the-icr-2011.jpg

photo: Julia Sero/the ICR

A combination of lapatinib and trastuzumab (Herceptin) before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days, according to new research more

News

The Antibiotic Research UK (ANTRUK) charity is launching its first research programme to test whether existing therapies for the treatment of medical conditions can reverse the antibiotic resistance of superbugs more

News

PanTher Therapeutics is developing an implantable device that delivers cancer drugs directly to the tumour more

News

Pharma companies have been teaming up in the fight against cancer. EPM lists the top 5 cancer fighting collaborations more

Opinion

A drug used to treat bone pain caused by cancer makes little difference to patients’ well-being, according to research by the University of Edinburgh more

News

Debiopharm International will collaborate with the European Organisation for Research and Treatment of Cancer (EORTC) in order to supply triptorelin pamoate for salivary gland cancer more

News

The US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review for Genentech’s venetoclax for the treatment of chronic lymphocytic leukaemia (CLL) more

News

Lenvatinib, discovered and developed by Eisai, has been submitted for review by the European Medicines Agency (EMA) for use in combination with everolimus to treat people with metastatic kidney cancer more

News

Research reveals that Palbociclib, an oral drug used to combat breast cancer also has the potential to combat lymphoma, sarcoma and teratoma cancers more

News